Word: drugging
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
TODD BRIDGES Diff'rent Strokes What you talkin' 'bout, Willis? The answer today: God. Bridges travels the U.S. speaking on his faith and recovery from drug addiction. He's also writing an autobiography, Finding Freedom...
...much too small--just 13 subjects in one case and 10 in the other--to be considered definitive. And both claim to be double-blind--a good thing in a research study, since it means that neither the testers nor the subjects are told who's getting which drug (or in this case, which drink) at any given time. But if you have ever tasted Gatorade and Accelerade, you might wonder whether the athletes could really have been fooled. It's not clear whether that knowledge could influence either performance or fluid retention, of course, but stranger things have happened...
...away, a quadruple homicide takes place, sending shock waves through the neighborhood. In the middle photo, Juanita Thomas, aunt to three of the victims, breaks down. In the early morning hours the next day, in the Fifth Ward, National Guardsmen, deployed to help police the city, interrogate a suspected drug dealer. Robbery and homicide numbers in New Orleans are nearing pre-Katrina levels, despite the drop-off in population. As drug dealers and gangs return to town, fierce turf battles have convulsed low-income neighborhoods, adding to the fear and uncertainty of already anxious returnees...
...what's a corporate lawyer doing atop the world's largest drug company? Saving it in court. The company is facing a flood of legal challenges. Among them: drugmaker Novo Nordisk recently claimed patent infringements for Pfizer's upcoming inhaled-insulin drug, Exubera, and Pfizer is being sued over Celebrex, its controversial Cox-2 inhibitor pain medication. Bonus points: Kindler knows his way around Washington, which should help Pfizer navigate the regulatory swamp. He has some operations cred too. At McDonald's, he led the turnaround of Boston Market...
...course, shrewd lawyering won't help Pfizer where it matters most: developing new medicines. Pfizer's biggest product, Lipitor, could lose its patent protection within four years. And Wall Street is losing patience with the pace of new-drug development. Pfizer's share price has slumped more than 30% since 2001. Former CEO McKinnell didn't help matters, appearing aloof to investor concerns while pocketing more than $140 million during his tenure, including a retirement package worth an estimated $83 million. Mending fences with shareholders will be critical for Kindler. They are, after all, paying his salary...